| Metric | Value (₹ Cr) | Q1 FY26 | Q2 FY25 |
|---|---|---|---|
| Revenue | 1.0K | 10.2% | 7.5% |
| Total Income | 1.0K | 9.6% | 8.6% |
| Expenditure | 922.96 | 0.5% | 4.9% |
| PBT | 103.01 | 52.4% | 58.3% |
| Net Profit | 88.93 | 48.8% | 81.9% |
| OPM | 12.99% | 8.90pp | 9.97pp |
| NPM | 8.67% | 6.65pp | 3.49pp |
| EPS | 3.62 | 49.7% | 78.3% |
Gallantt Ispat Ltd. Approves Unaudited Financial Results for Q2 & H1 2025, Announces Sale of Shares in Associates and Plans for Solar Power Plant
03 Nov 2025 · 3 Nov 2025, 05:35 pm
Summary
The Board of Directors of Gallantt Ispat Ltd. has approved the unaudited financial results for the quarter and half year ended 30th September, 2025. The company has also announced the sale of its entire shareholding in Gallantt Medicity Devlopers Private Limited and Gallantt Lifespace Devlopers Private Limited, both associates of the company. Furthermore, the board has proposed to set up an 18 MW Solar Power Plant at Village — Khelaru, Taluka — Shidpur, Dist - Mehsana, Gujarat.
Key Highlights
- 1
Unaudited financial results for Q2 & H1 2025 approved
- 2
Sale of shares in associates Gallantt Medicity Devlopers Private Limited and Gallantt Lifespace Devlopers Private Limited announced
- 3
Proposal to set up an 18 MW Solar Power Plant at Village — Khelaru, Taluka — Shidpur, Dist - Mehsana, Gujarat
Management Comments
C.P. Aarawal
C.P. Aarawal, Managing Director
Informational and educational content only. Not investment advice.